Davangere P Devanand1, Seonjoo Lee2, Jennifer Manly3, Howard Andrews3, Nicole Schupf3, Arjun Masurkar3, Yaakov Stern3, Richard Mayeux3, Richard L Doty4. 1. Division of Geriatric Psychiatry, Department of Psychiatry, Columbia University, New York, NY. 2. Division of Biostatistics, New York State Psychiatric Institute and Columbia University, New York, NY. 3. Department of Neurology, Gertrude H. Sergievsky Center, and Taub Institute for Research on Alzheimer's Disease and the Aging Brain, College of Physicians and Surgeons, Columbia University, New York, NY. 4. Smell and Taste Center, University of Pennsylvania, Philadelphia, PA.
Abstract
OBJECTIVE: To examine the association between odor identification deficits and future mortality in a multiethnic community cohort of older adults. METHODS:Participants were evaluated with the 40-item University of Pennsylvania Smell Identification Test (UPSIT). Follow-up occurred at 2-year intervals with information on death obtained from informant interviews and the National Death Index. RESULTS: During follow-up (mean = 4.1 years, standard deviation = 2.6), 349 of 1,169 (29.9%) participants died. Participants who died were more likely to be older (p < 0.001), be male (p < 0.001), have lower UPSIT scores (p < 0.001), and have a diagnosis of dementia (p < 0.001). In a Cox model, the association between lower UPSIT score and mortality (hazard ratio [HR] = 1.07 per point interval, 95% confidence interval [CI] = 1.05-1.08, p < 0.001) persisted after controlling for age, gender, education, ethnicity, language, modified Charlson medical comorbidity index, dementia, depression, alcohol abuse, head injury, smoking, body mass index, and vision and hearing impairment (HR = 1.05, 95% CI = 1.03-1.07, p < 0.001). Compared to the fourth quartile with the highest UPSIT scores, HRs for mortality for the first, second, and third quartiles of UPSIT scores were 3.81 (95% CI = 2.71-5.34), 1.75 (95% CI = 1.23-2.50), and 1.58 (95% CI = 1.09-2.30), respectively. Participant mortality rate was 45% in the lowest quartile of UPSIT scores (anosmia) and 18% in the highest quartile of UPSIT scores. INTERPRETATION: Impaired odor identification, particularly in the anosmic range, is associated with increased mortality in older adults even after controlling for dementia and medical comorbidity.
RCT Entities:
OBJECTIVE: To examine the association between odor identification deficits and future mortality in a multiethnic community cohort of older adults. METHODS:Participants were evaluated with the 40-item University of Pennsylvania Smell Identification Test (UPSIT). Follow-up occurred at 2-year intervals with information on death obtained from informant interviews and the National Death Index. RESULTS: During follow-up (mean = 4.1 years, standard deviation = 2.6), 349 of 1,169 (29.9%) participants died. Participants who died were more likely to be older (p < 0.001), be male (p < 0.001), have lower UPSIT scores (p < 0.001), and have a diagnosis of dementia (p < 0.001). In a Cox model, the association between lower UPSIT score and mortality (hazard ratio [HR] = 1.07 per point interval, 95% confidence interval [CI] = 1.05-1.08, p < 0.001) persisted after controlling for age, gender, education, ethnicity, language, modified Charlson medical comorbidity index, dementia, depression, alcohol abuse, head injury, smoking, body mass index, and vision and hearing impairment (HR = 1.05, 95% CI = 1.03-1.07, p < 0.001). Compared to the fourth quartile with the highest UPSIT scores, HRs for mortality for the first, second, and third quartiles of UPSIT scores were 3.81 (95% CI = 2.71-5.34), 1.75 (95% CI = 1.23-2.50), and 1.58 (95% CI = 1.09-2.30), respectively. Participant mortality rate was 45% in the lowest quartile of UPSIT scores (anosmia) and 18% in the highest quartile of UPSIT scores. INTERPRETATION: Impaired odor identification, particularly in the anosmic range, is associated with increased mortality in older adults even after controlling for dementia and medical comorbidity.
Authors: Matthias H Tabert; Xinhua Liu; Richard L Doty; Michael Serby; Diana Zamora; Gregory H Pelton; Karen Marder; Mark W Albers; Yaakov Stern; D P Devanand Journal: Ann Neurol Date: 2005-07 Impact factor: 10.422
Authors: L Philip Schumm; Martha McClintock; Sharon Williams; Sara Leitsch; Johan Lundstrom; Thomas Hummel; Stacy Tessler Lindau Journal: J Gerontol B Psychol Sci Soc Sci Date: 2009-06-23 Impact factor: 4.077
Authors: Anja Diem-Zangerl; Klaus Seppi; Gregor K Wenning; Eugen Trinka; Gerhard Ransmayr; Wilhelm Oberaigner; Werner Poewe Journal: Mov Disord Date: 2009-04-30 Impact factor: 10.338
Authors: David S Goldstein; Courtney Holmes; Oladi Bentho; Takuya Sato; Jeffrey Moak; Yehonatan Sharabi; Richard Imrich; Shielah Conant; Basil A Eldadah Journal: Parkinsonism Relat Disord Date: 2008-03-05 Impact factor: 4.891
Authors: Brian London; Behnam Nabet; Andrew R Fisher; Brigitte White; Mary D Sammel; Richard L Doty Journal: Ann Neurol Date: 2008-02 Impact factor: 10.422
Authors: David R Roalf; Madelyn J Moberg; Bruce I Turetsky; Laura Brennan; Sushila Kabadi; David A Wolk; Paul J Moberg Journal: J Neurol Neurosurg Psychiatry Date: 2016-12-30 Impact factor: 10.154
Authors: Megan Quarmley; Paul J Moberg; Dawn Mechanic-Hamilton; Sushila Kabadi; Steven E Arnold; David A Wolk; David R Roalf Journal: J Alzheimers Dis Date: 2017 Impact factor: 4.472
Authors: Gaurav S Ajmani; Helen H Suh; Kristen E Wroblewski; David W Kern; L Philip Schumm; Martha K McClintock; Jeff D Yanosky; Jayant M Pinto Journal: Environ Res Date: 2016-09-29 Impact factor: 6.498
Authors: Priya Palta; Honglei Chen; Jennifer A Deal; A Richey Sharrett; Alden Gross; David Knopman; Michael Griswold; Gerardo Heiss; Thomas H Mosley Journal: Alzheimers Dement Date: 2018-03-30 Impact factor: 21.566